Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4844134

Brc1cnc2[nH]c(-c3ccc(NCc4cc[nH]n4)cc3)nc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 4/20 0.36
MMP2 P08253 5/20 0.34
MMP9 P14780 5/20 0.34
MMP8 P22894 5/20 0.34
MMP13 P45452 5/20 0.34
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
FFAR1 O14842 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5258008 0.91 HPSE (0.35) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4838725 0.85 MMP2 (0.34) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4845670 0.84 FFAR1 (0.42) HPSEHDAC1FFAR1
Trifluoroacetic Acid SCHEMBL4837278 0.84 HPSE (0.45) HPSEFFAR1
Trifluoroacetic Acid SCHEMBL4841657 0.84 TAAR1 (0.41) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4842251 0.83 TPH1 (0.37) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4844349 0.83 HPSE (0.36) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL5259763 0.83 MMP2 (0.35) HPSEMMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4839090 0.82 GPR6 (0.43) MMP2MMP9MMP8MMP13HDAC3
Trifluoroacetic Acid SCHEMBL4846619 0.82 MMP2 (0.35) HPSEMMP2MMP9MMP8MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 HPSE 4318/4885MMP2 3540/4885MMP9 4224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.